The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
For several weeks gun enthusiasts have been nervously watching the U.S. Supreme Court. The highest court has flirted with granting certiorari and agreeing to hear two noteworthy gun-related cases ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
People were getting hit over the head with bottles and police had to resort to using pepper spray guns inside the strip club. The strip club was advised to shut down for the night. According to the ...
SPRINGFIELD — A collaborative effort between local and federal law enforcement agencies has resulted in multiple arrests and the seizure of illegal firearms and drugs in an operation aimed at ...
This study proposes an electric bus system optimization method considering vehicles to charging guns compatibility and multi-gun fast charging, in which BEBs can be charged by multiple charging guns ...
In a joint statement, Neylon and Wanggaard said: "We are offering this legislation to encourage people to store guns securely, and keep children safe from accidental injury, death, and suicide.
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Taake, of Houston, was sentenced to a little more than six years for assaulting law enforcement officers with bear spray and a metal ... used a stun gun and plunged it into the neck of Washington ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results